RYI Form 4: 382-Share Director Grant Vesting on 09/30/2025

Rhea-AI Filing Summary

Ryerson Holding Corp director Kirk K. Calhoun received an equity award under the companys Director Compensation Program that vested in full on the grant date. The reported transaction dated 09/30/2025 shows an acquisition of 382 shares of common stock at a reported price of $0 as compensation. Following the award, the reporting person beneficially owns 3,840 shares, held directly. The filing is a Form 4 reporting a routine, vested director equity grant disclosed under Section 16 reporting rules and was signed by an attorney-in-fact on 10/02/2025. The filer checked the box indicating they are a Director.

Positive

• 382 shares granted and vested immediately under the Director Compensation Program
• Directors direct beneficial ownership increased to 3,840 shares
• Transaction recorded as compensation (price $0), indicating no cash outlay by the director

Negative

• None.

Insights

Corporate Governance Analyst

Director received a vested equity award of 382 shares on 09/30/2025, increasing direct holdings to 3,840 shares.

The Form 4 discloses a routine director compensation payment: 382 shares were granted and vested immediately as part of Ryersons Director Compensation Program, recorded with a transaction price of $0 which reflects a compensatory grant rather than an open-market purchase.

This filing is informational for shareholders and regulators, showing no sale or dilution event and confirming the directors direct beneficial ownership of 3,840 shares after the grant.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

CALHOUN KIRK K

(Last) (First) (Middle)

C/O RYERSON HOLDING CORPORATION

227 W. MONROE ST., 27TH FLOOR

(Street)

CHICAGO IL 60606

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Ryerson Holding Corp [ RYI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock (par value $0.01 per share)	09/30/2025		A		382(1)	A	$0	3,840	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects compensation in the form of equity received pursuant to Ryerson's Director Compensation Program. The award vested in full on the grant date.

	/s/ Camilla Rykke Merrick, attorney-in-fact	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Ryerson (RYI) report in the Form 4 filed for 09/30/2025?

The Form 4 reports that director Kirk K. Calhoun was granted and vested 382 shares as director compensation on 09/30/2025.

How many Ryerson (RYI) shares does the reporting director own after the transaction?

After the grant, the reporting person beneficially owns 3,840 shares of Ryerson common stock.

Was the 09/30/2025 stock award for Ryerson paid in cash?

No. The transaction lists a price of $0, indicating the shares were issued as compensation rather than purchased for cash.

Who signed the Form 4 for the Ryerson filing and when?

The Form 4 was signed by Camilla Rykke Merrick, attorney-in-fact on 10/02/2025.

What role does the reporting person have at Ryerson (RYI)?

The reporting person, Kirk K. Calhoun, is identified as a Director of Ryerson Holding Corp.